Baxter International stock slips as Q2 beat and raise still matters

Published on 09/19/2026 at 10:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Baxter International stock closed at USD 22.79 on September 18, 2026, after a 0.98 percent drop. MarketBeat shows a USD 22.45 consensus target and a Hold rating.

Isometrische 3D-Illustration der Medizinprodukt-Lieferkette von Produktion bis Krankenhaus — Isometrisches 3D-Diagramm der Wertschöpfungskette von Baxter International Inc. Medizinprodukten mit ISIN US0673431090 illustriert, Illustration mit AI erstellt.

Baxter International stock (ISIN US0673431090) closed at USD 22.79 on September 18, 2026, after falling 0.98 percent. MarketBeat put the market value at USD 11.78 billion and the 52-week range at USD 15.73 to USD 30.00.

Q2 beat still sets the tone

For the latest reported quarter, Baxter said on July 30, 2026 that non-GAAP EPS was USD 0.56, beating consensus by USD 0.19, while revenue reached USD 2.96 billion, or USD 160 million above estimates. MarketBeat also shows trailing sales of USD 11.24 billion and net income of minus USD 957 million.

The same update also pointed to 2026 organic sales growth of 2 percent to 3 percent and EPS of USD 1.95 to USD 2.15 for the full year, giving investors a clear operating range to track into the next report. That makes the margin path more important than the single-day move.

Consensus stays cautious

According to MarketBeat, Baxter International carries a Hold consensus with a price target of USD 22.45, based on 13 analysts, while the low and high targets stand at USD 15.00 and USD 28.00. The stock's latest close of USD 22.79 sits 21.0 percent below the 52-week high and 44.8 percent above the 52-week low.

MarketBeat also lists 9.97 million shares of volume against average volume of 4.91 million, showing heavier-than-usual trading on September 18, 2026. The market is still weighing the Q2 beat against the full-year guide.

Stock near mid-range

Baxter International stock ended September 18, 2026 at USD 22.79, with extended trading at USD 22.82. MarketBeat also showed a market capitalization of USD 11.78 billion, keeping the shares in the middle of the 52-week band.